Novo Nordisk has secured a significant regulatory victory, following the United States Food and Drug Administration’s approval of its new weight loss pill containing semaglutide. The decision delivers the Danish
All posts tagged in semaglutide
5Articles
Scotland’s National Health Service saw a dramatic increase in the prescription of semaglutide, known commercially as Ozempic and Wegovy, as the annual number of prescriptions rose to 168,486 in 2024
Denmark’s pharmaceutical powerhouse Novo Nordisk is set to axe 9000 jobs, marking one of the most substantial workforce reductions in its history, as the company battles a steeply declining share
A major rise in the cost of Mounjaro is set to impact more than a million weight loss patients across Britain next month amid an international dispute over medicine prices.
The pharmaceutical industry stands on the cusp of a major transformation as revolutionary weight-loss injections demonstrate potential far beyond their initial scope. Semaglutide, marketed under brands like Ozempic and Wegovy,
